5,N,N-TMT

5,N,N-TMT
	File:5,N,N-TMT.svg
Gene therapy
Clinical data
Physiological data
Legal status
Pharmacokinetic data
Identifiers
	IUPAC name (2-(5-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine;
CAS Number	22120-39-4;
PubChem Template:Abbreviation	1837;
Chemical and physical data
Formula	C13H18N2
Molar mass	202.30 g/mol

5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was first made in 1958 by E. H. Young. ^[1] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency ^[2] ^[3] which would suggest an active dosage for humans in the 20-60mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.

References

↑ Young EH, J. Chem. Soc. 3493 (1958)
↑ Glennon et al, J. Med. Chem. 22:428-432 (1979)
↑ Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities.Psychopharmacology (Berlin). 1980 May, 68(2): 155-158

Template:Hallucinogenic tryptamines Template:Hallucinogen-stub

Template:WikiDoc Sources

[1] Young EH, J. Chem. Soc. 3493 (1958)

[2] Glennon et al, J. Med. Chem. 22:428-432 (1979)

[3] Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities.Psychopharmacology (Berlin). 1980 May, 68(2): 155-158

[1]

[2]

[3]

5,N,N-TMT

References

Navigation menu

Search